4.5 Article

Gln27→Gluβ2-Adrenergic Receptor Polymorphism in Heart Failure Patients: Differential Clinical and Oxidative Response to Carvedilol

期刊

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
卷 104, 期 5, 页码 374-378

出版社

WILEY-BLACKWELL
DOI: 10.1111/j.1742-7843.2008.00370.x

关键词

-

资金

  1. FONDECYT [1010992]
  2. FONDAP [15010006]
  3. DID [14-02/01]

向作者/读者索取更多资源

We investigated the clinical response of chronic heart failure patients with beta(2)- adrenergic receptor Gln(27)-> Glu polymorphism treated for 6 months with carvedilol, a alpha/beta-antagonist with antioxidant properties. The 6-min. walk test, the left ventricular ejection fraction, heart rate, plasma norepinephrine and malondialdehyde, a stress oxidative marker, concentrations were evaluated at baseline and after treatment for 6 months with carvedilol in 33 stable chronic heart failure patients with the Gln(27)-> Glu beta(2)-adrenergic receptor polymorphism. Carvedilol significantly increased the left ventricular ejection fraction, while decreasing the heart rate and malondialdehyde plasma concentrations in chronic heart failure patients with the Glu(27)->beta(2)-adrenergic receptor allele. There were however, no significant changes in patients with the Gln(27)->beta(2)-adrenergic receptor variant.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据